
Opinion|Videos|July 18, 2024
Comparative Analysis: Deucravacitinib and Adalimumab in Psoriasis Treatment
Medical professionals discuss ongoing clinical trials and novel medications for the treatment of psoriasis.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement




















